Speaking Valve Combined With Airway Pressure Predicts Upper Airway Patency in Adult Tracheotomized Patients
NCT ID: NCT06521320
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
248 participants
INTERVENTIONAL
2021-10-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Tracheostomy Tube That Enables Communication
NCT02018562
Assessing Upper Airway Patency in Tracheostomy Patients During One Way Speaking Valve Trial
NCT04685902
Safe Use of Speaking Valve in Children During Sleep Using Trans-tracheal Pressure Measurement
NCT02935140
Cough Flow as a Criterion Decannulation Threshold in Prolonged Tracheostomy Patients
NCT07317791
Combined Ultrasonographic Skin-to-Epiglottis Distance With Modified Mallampati Versus Modified Mallampati Score Alone in Predicting Difficult Laryngoscopy During Tracheal Intubation Under General Anesthesia
NCT07315256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Upper airway patency
Upper airway patency confirmed by speaking valve combined with airway pressure measurement or bronchoscopy
speaking valve combined with airway pressure
All patients were given speaking valves and airway pressure was measured to assess upper airway patency.
Bronchoscopy
The same examiner performed bronchoscopy on all patients to assess upper airway patency.
Upper airway obstruction
Upper airway obstruction confirmed by speaking valve combined with airway pressure measurement or bronchoscopy
speaking valve combined with airway pressure
All patients were given speaking valves and airway pressure was measured to assess upper airway patency.
Bronchoscopy
The same examiner performed bronchoscopy on all patients to assess upper airway patency.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
speaking valve combined with airway pressure
All patients were given speaking valves and airway pressure was measured to assess upper airway patency.
Bronchoscopy
The same examiner performed bronchoscopy on all patients to assess upper airway patency.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No any organ failure
* No sepsis
* Stable heart rate and blood pressure
* Lung infection under control
* PCO2\<60mmHg
* Patient and family sign informed consent form
Exclusion Criteria
* Unable tolerance of cuff deflated
* Laryngopharyngeal trauma
* Known severe upper airway obstruction before referrer to our department
* Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jingyi Ge
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingyi Ge
Role: PRINCIPAL_INVESTIGATOR
specify unaffiliated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Rehabilitation Hospital of Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021Z-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.